[ Price : $8.95]
A new report from Avalere Health on advisory committee trends finds that CDERs Cardiovascular and Renal Drugs Committee has recomm...[ Price : $8.95]
An FDA drug safety review leads to warnings being added to Type 2 diabetes drugs called sodium-glucose cotransporter-2 inhibitors ...[ Price : $8.95]
Eli Lilly decides to stop developing basal insulin peglispro, a potential treatment for Type 1 and Type 2 diabetes due to disappoi...[ Price : $8.95]
Amgen and Merck announce two cancer immunotherapy collaborations to support combination therapies in patients with diffuse large B...[ Price : $8.95]
Federal Register Notice: FDA determines that 14 drug products were not withdrawn from sale for reasons of safety or effectiveness.[ Price : $8.95]
Mylan says one of its subsidiaries has received a subpoena from the Justice Departments Antitrust Division seeking information rel...[ Price : $8.95]
FDA posts a draft guidance on Best Practices for Communication Between IND Sponsors and FDA During Drug Development.[ Price : $8.95]
FDA clears an ADC Therapeutics IND to begin clinical trials with ADCT-402, a novel antibody drug conjugate targeting CD19, a cell-...